Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Daniel Bradbury, Robert Epstein, Roy Whitfield, Francis deSouza, and Others

Premium

Illumina stockholders have voted to re-elect four members of its board of directors, approving three-year terms on the board for Daniel Bradbury, Robert Epstein, and Roy Whitfield, and a two-year term for President Francis deSouza.


Singulex has appointed Peter Heseltine as chief medical officer. Heseltine is professor of clinical medicine at the University of California, Irvine. Previously, he was senior vice president and chief medical officer at Prometheus Laboratories. He also held executive positions at Beckman Coulter and Quest Diagnostics.


Enzo Biochem has appointed James O'Brien as senior VP of finance, succeeding Andrew Crescenzo, who is leaving the company. Enzo also said that former Chief Operations Officer Andrew Whiteley has resigned.

O'Brien most recently was VP and corporate controller for Actavis; has held senior finance posts at Nycomed US, Aptuit, Purdue Pharma, and Bristol Myers Squibb; and began his career as an accountant at Pricewaterhouse Coopers.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.